Hanmi-MSD’s export agreement of ‘Rosuzet,’ hyperlipidemia combination drug, to 23 countries

Hanmi-developed ‘Rosuzet’ will be exported to 23 foreign countries via MSD.

It was announced on the 4^th Hanmi Pharm and MSD has recently signed a license agreement of exporting Rosuzet and decided to export three different volumes of Rosuzet(10/5mg, 10/10mg and 10/20mg) to 23 countries.

Rosuzet, a drug combined with a hyperlipidemia treatment, ‘rosuvastatin’ and ‘ezetimibe,’ is a ETC drug tha...